The study compares manufacturer prices in Australia and seven other countries for 150 pharmaceuticals listed on the Pharmaceutical Benefits Scheme (PBS), as at 30 June 2000. The comprehensive study found that prices in the USA are between 80 to 160 per cent higher than in Australia, and prices...

In 2004, the Australian Government asked the Productivity Commission to look at the impact on the economy and the community of NCP and related reforms and for areas which offer opportunities for significant gains. The Commission found that the benefits of NCP have greatly outweighed the costs....